A 32-year-old woman with poorly controlled diabetes mellitus presents with vulvovaginal candidiasis confirmed by clinical examination. She has recurrent episodes over the past 6 months. Which investigation is most appropriate to identify the causative Candida species and guide species-specific antifungal therapy?

## Investigation of Choice for Candida Species Identification ### Clinical Context While germ tube test and culture are standard screening tools, **species identification** is essential in recurrent candidiasis to: - Identify non-albicans species (C. glabrata, C. auris, C. tropicalis) which may have reduced azole susceptibility - Guide targeted antifungal therapy - Assess infection severity and treatment failure risk ### Gold Standard Methods for Species Identification | Investigation | Sensitivity | Specificity | Time | Clinical Use | |---|---|---|---|---| | **MALDI-TOF MS / DNA probe** | 95–99% | 98–100% | 2–4 hrs post-culture | Gold standard; species-level ID | | Germ tube test | 65–90% | 98% | 2–3 hrs | Screens for C. albicans only | | Morphology on CHROMagar | 85–95% | 90% | 24–48 hrs | Presumptive ID; limited species | | 18S rRNA sequencing | 99% | 99% | 3–5 days | Reference standard; not routine | ### Why MALDI-TOF / DNA Probe is Superior **Key Point:** MALDI-TOF mass spectrometry and DNA probe assays provide **rapid, accurate, species-level identification** and are now the reference standard in most high-volume mycology labs. They distinguish C. albicans from non-albicans species, which is critical for: - C. glabrata: often fluconazole-resistant; requires echinocandin or voriconazole - C. auris: multidrug-resistant; requires echinocandin - C. tropicalis: higher virulence; invasive disease risk **High-Yield:** In recurrent or treatment-refractory candidiasis, **always perform species identification**. Non-albicans species account for 20–30% of vaginal isolates in some populations and require different management. **Clinical Pearl:** Germ tube test is a **screening tool only** — it cannot identify non-albicans species and should never be the sole identification method in recurrent infections. ### Diagnostic Algorithm ```mermaid flowchart TD A[Suspected Candida infection]:::outcome --> B[Culture on SDA]:::action B --> C{Presumptive ID needed?}:::decision C -->|Rapid screening| D[Germ tube test]:::action C -->|Species ID required| E[MALDI-TOF or DNA probe]:::action D --> F[C. albicans?]:::decision F -->|Yes| G[Fluconazole]:::action F -->|No| E E --> H[Species identified]:::outcome H --> I[Susceptibility-guided therapy]:::action ``` **Mnemonic:** **MALDI** = **M**ass **A**nalysis of **L**aser **D**esorption/**I**onization — a protein fingerprinting technique that rapidly identifies fungi to species level.